# A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®

> **NCT02627287** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 150 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** FlexPen®
- **DEVICE:** DV3316 pen-injector
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02627287
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-01
- **Primary completion:** 2016-02-25
- **Final completion:** 2016-02-25
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627287, "A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02627287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*